Investor Info current investors

BioAdvance
BioAdvance's mission is to accelerate the growth of the life sciences industry in Southeastern Pennsylvania by transforming the region's strengths in biomedical research into commercial opportunities. BioAdvance was founded as part of a $2 billion initiative by the Commonwealth of Pennsylvania to strengthen its commitment to the life sciences. Additional information is available at www.bioadvance.com.

Osage Ventures
Osage Ventures is a venture capital fund that seeks to invest in determined and creative entrepreneurs that have a unique concept or product. Osage provides capital and value-added services to early-stage information and enabling technology and life science/healthcare businesses in the Northeast corridor. Initial investments range from $1 -- 1.5 million. Additional information is available at www.osageventures.com.

Mid-Atlantic Angel Group
The Mid-Atlantic Angel Group Fund I, LP (MAG) was created to bridge the gap between angel funding and institutional venture capital funding serving the Greater Philadelphia Region. This member-managed fund provides its investors with an opportunity for active involvement in diversified venture capital investments throughout Southeastern Pennsylvania, Central and Southern New Jersey, and Delaware. The fund seeks to leverage various public and private funding resources and networks by providing equity capital to seed and early-stage, technology-based, high-growth companies. Additional information is available at www.magfund.com.

Cammeby's Capital Group
Cammeby's Capital Group is the investment arm of Cammeby's International, a private family owned real estate firm which owns, develops, and manages real estate throughout the U.S. Cammeby's International owns and manages more than 25,000 residential units and more than 10 million sq. ft. of commercial and industrial space. In addition to Cammeby's real estate holdings, notable transactions include the purchase of a controlling interest in Israel Discount Bank along with the Bronfman family. Cammeby's Capital Group focuses on early and growth stage opportunities in the life sciences, medical device, advanced materials, information technology infrastructure and communications industries.

Venture East
Ventureast is one of the highly experienced fund managers in India, now on to its “third” generation of funds, with close to $300 million under management. We are a fund manager that is entrepreneurial in our origins, not affiliated to or sponsored by an institution either Indian or overseas. Ventureast is one of the handful of teams in india that have been investing through the last economic downturn, and one of even fewer partnerships that have stayed together from before that period.

We are a stage agnostic fund manager but with a penchant for venture style investing. Our funds are focused on market based themes rather than on specific industry verticals. Our funds include those that focus on meeting health care needs of the market, irrespective of whether the solution is driven by biotechnology/pharmacology or innovative business models. Similarly, our technology fund is focused on the needs of semi-urban rural markets and the needs of small/medium enterprises (SMEs) , irrespective of whether the solution is derived from ICT, or a business model change.

Our consistent theme through the years is to “differentiate” in investing, in deal generation, in our working style with entrepreneurs; and in our choice of investors. We are passionate about our portfolio companies, we are extremely hands-on, and we have delivered great returns. One investor said about us, “you make money, but you make it differently“.

Back to top of page